Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 1/20 | 0.58 |
| ▸ | FYN | P06241 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | GFER | P55789 | 1/20 | 0.42 |
| ▸ | CLCN2 | P51788 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15795417 | 0.93 | LCK (0.62) | LCKFYNALDH1A1KDM4EHPGD | |
| SCHEMBL10712499 | 0.87 | LCK (0.59) | LCKFYNALDH1A1KDM4EHPGD | |
| SCHEMBL31096338 | 0.87 | LCK (0.59) | LCKFYNALDH1A1KDM4EHPGD | |
| SCHEMBL30356409 | 0.86 | HTT (0.46) | LCKFYNALDH1A1HPGDHTT | |
| SCHEMBL29025712 | 0.86 | HTT (0.46) | LCKFYNALDH1A1HPGDHTT | |
| Hydrochloric Acid SCHEMBL10980399 | 0.86 | LCK (0.58) | LCKFYNALDH1A1KDM4EHPGD | |
| SCHEMBL25339845 | 0.85 | LCK (0.71) | LCKFYNALDH1A1KDM4EHPGD | |
| SCHEMBL1918763 | 0.85 | LCK (0.66) | LCKFYNALDH1A1KDM4EHPGD | |
| SCHEMBL30448157 | 0.85 | LCK (0.71) | LCKFYNALDH1A1KDM4EHPGD | |
| SCHEMBL2818164 | 0.85 | LCK (0.60) | LCKFYNALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2714032-B1 | NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS | GREEN CROSS CORP (KR) | 2019-01-16 | — | — | EP | disclosed |
| US-9371303-B2 | Diphenylmethane derivatives as SGLT2 inhibitors | GREEN CROSS CORPORATION (KR) | 2016-06-21 | — | — | US | disclosed |
| US-20150152075-A1 | NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2015-06-04 | — | — | US | disclosed |
| US-9034921-B2 | Diphenylmethane derivatives as SGLT2 inhibitors | GREEN CROSS CORPORATION (KR) | 2015-05-19 | — | — | US | disclosed |
| US-8921412-B2 | C-aryl ansa SGLT2 inhibitors | GREEN CROSS CORPORATION (KR) | 2014-12-30 | — | — | US | disclosed |
| US-8921412-B2 | C-aryl ansa SGLT2 inhibitors | GREEN CROSS CORPORATION (KR) | 2014-12-30 | — | — | US | disclosed |
| US-8921412-B2 | C-aryl ansa SGLT2 inhibitors | GREEN CROSS CORPORATION (KR) | 2014-12-30 | — | — | US | disclosed |
| US-20140213642-A1 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2014-07-31 | — | — | US | disclosed |
| US-20140213642-A1 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2014-07-31 | — | — | US | disclosed |
| US-20140213642-A1 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2014-07-31 | — | — | US | disclosed |
| US-20130090298-A1 | Thiazole Derivatives as SGLT2 Inhibitors and Pharmaceutical Composition Comprising Same | GREEN CROSS CORPORATION (KR) | 2013-04-11 | — | — | US | disclosed |
| WO-2012173410-A2 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012173410-A2 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012165914-A2 | NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS | GREEN CROSS CORPORATION (KR) | 2012-12-06 | — | — | WO | disclosed |
| US-20120101051-A1 | NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | GREEN CROSS CORPORATION (KR) | 2012-04-26 | — | — | US | disclosed |
| US-20120101051-A1 | NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | GREEN CROSS CORPORATION (KR) | 2012-04-26 | — | — | US | disclosed |
| WO-2011159067-A2 | THIAZOLE DERIVATIVES AS SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GREEN CROSS CORPORATION (KR) | 2011-12-22 | — | — | WO | disclosed |
| WO-2011159067-A2 | THIAZOLE DERIVATIVES AS SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GREEN CROSS CORPORATION (KR) | 2011-12-22 | — | — | WO | disclosed |
| WO-2010147430-A2 | NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GREEN CROSS CORPORATION (KR) | 2010-12-23 | — | — | WO | disclosed |
| WO-2010147430-A2 | NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GREEN CROSS CORPORATION (KR) | 2010-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130090298-A1 | Thiazole Derivatives as SGLT2 Inhibitors and Pharmaceutical Composition Comprising Same | SLC5A2, SLC5A1, SLC10A2 | LCK 1362/4885FYN 2663/4885ALDH1A1 1292/4885 |
| US-20120101051-A1 | NOVEL C-ARYL GLUCOSIDE SGLT2 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | SLC5A2, SLC5A1, SLC2A2 | LCK 1747/4885FYN 2400/4885ALDH1A1 1785/4885 |
| US-20140213642-A1 | NOVEL C-ARYL ANSA SGLT2 INHIBITORS | SLC5A2, SLC5A1, SLC2A1 | LCK 4119/4885FYN 3925/4885ALDH1A1 550/4885 |
| US-20150152075-A1 | NOVEL DIPHENYLMETHANE DERIVATIVES AS SGLT2 INHIBITORS | SLC5A2, SLC5A1, SLC2A8 | LCK 1774/4885FYN 3412/4885ALDH1A1 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.